News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Takeda Pharmaceutical Co. Ltd. Introduces New Measles-Rubella Vaccine
January 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Jan 31, 2006 (JCN) - Takeda Pharmaceutical announced on January 30 that it has launched Takeda, its proprietary measles-rubella (MR) vaccine.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Takeda
MORE ON THIS TOPIC
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
·
1 min read
·
Annalee Armstrong
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
June 24, 2026
·
2 min read
·
Tristan Manalac
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
June 24, 2026
·
2 min read
·
Annalee Armstrong
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
June 22, 2026
·
2 min read
·
Gabrielle Masson
